The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy.
Glenmark Pharma to divest 75% stake in life sciences unit for $680m
Glenmark Pharma continues to maintain growth across all its crucial markets. Credit: T. Schneider/Shutterstock.com. Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75%